ALPHA MOS overview

25 April 2024 – 8:00 am FY 2023 RESULTS Annual revenues down 22%. 2024: positive outlook driven by deployment with key accounts and the launch of new applications The financial information presented in this press release is extracted from the financial statements reviewed by the Audit Committee on 22 April 2024 and approved by the Board of Directors on 24 April 2024. Details are given in the audited reports and notes published online on 24 April. In €'000 - IFRS –audited data 2023 2022...

Alpha MOS (FR0013421286 ALNEO), world leader in odor, taste and industrial visual analyzers, announces the completion by its Medtech subsidiary BOYDSense of a 7-million-euro capital increase, including €1.5 million by conversion of convertible bonds subscribed in 2023 and €5.5 million of new money. While remaining majority-owned by Alpha MOS, BOYDSense thus acquires the means to pursue autonomously the development of its non-invasive glucose monitoring device for people with diabetes. This...

Toulouse, October 30th, 2023, 6:00pm INTERIM RESULTS AT 30 JUNE 2023 Revenues up 14% Foodtech: substantial advances with key accounts Medtech: promising results from 2nd clinical study Alpha MOS (FR0013421286 ALNEO), world leader in odor, taste and visual analyzers for the industry, publishes its interim results at 30 June 2023, as approved by the Board of Directors on 27 October 2023. (€'000, IFRS, audited data) H1 2023 H1 2022 Change Revenues 2,744 2,397 347 EBITDA (1,561) (955) (606)...

Alpha MOS (FR0013421286 ALNEO), world leader in smell, taste and visual industrial instrument analyzers, announces the on-schedule completion of the 2nd clinical study on the non-invasive breath glucose monitoring device developed by its Medtech subsidiary, BOYDSense. The study, promoted by Toulouse University Hospital (CHU) and launched in late 2021 by the Diabetology, Metabolic Diseases and Nutrition research team, involved 130 patients with type 2 diabetes. The results will be the subject of...

Alpha MOS (FR0013421286 ALNEO), world leader in odor, taste and visual analyzers for the industry, announces the official validation of its solution for milk quality control by the Chinese group Mengniu, 7th largest dairy group 1 in the world and n°1 in China. This validation comes 6 months after the signature of a 2-year framework contract with the distribution company Lan Chou Instruments to equip Mengniu with Heracles NEO electronic noses 2 . Mengniu is used to testing the most advanced...

PRESS RELEASE Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes Toulouse (France) and Vienna (Austria), October 2nd, 2020. Sweet Ventures entered into an investment agreement to support the development of Alpha MOS' subsidiary BOYDSense into a leading provider of non-invasive breath analysis-based solutions to monitor diabetes and other chronic conditions. Sweet Ventures is an investment group formed by the founders and...